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Preferential Effect of Procainamide on the Reentrant Circuit of
Ventricular Tachycardia
G. NEAL KAY, MD, ANDREW E. EPSTEIN, MD, FACC, VANCE J . PLUMB, MD, FACC
Birmingham, Alabama
Transient entrainment was used to test the hypotheses that
1) procainamide prolongs the cycle length of ventricular
tachycardia in patients with coronary artery disease be-
cause it has a preferential effect on the reentrant tachycar-
dia circuit, and ) regions of slow conduction in the
reentrant circuit are more susceptible to the effect of
procainamide than are other areas of the ventricles . In five
patients with prior myocardial infarction, sustained ven-
tricular tachycardia with identical QRS configuration was
inducible before and after intravenous infusion of procain-
amide. Transient entrainment of ventricular tachycardia
was demonstrated at two or more cycle lengths by rapid
pacing in the baseline state and after procainamide . Rapid
pacing was performed from the same site during sinus
rhythm at the cycle lengths that demonstrated transient
entrainment of ventricular tachycardia . The conduction
interval to the transiently entrained site during ventricular
tachycardia (orthodromic interval) was compared with the
conduction interval to the same site during pacing in sinus
rhythm (antidromic interval) .
The mean tachycardia cycle length increased by 7%
Procainamide and other type I antiarrhythmic agents are
often effective in prolonging the cycle length of ventricular
tachycardia (1) . The mechanism responsible for the effec-
tiveness of these drugs to slow down the rate of ventricular
tachycardia in humans is incompletely understood . Antiar-
rhythmic agents have a wide range of potential electrophys-
iologic effects, including changes in myocardial conduction,
refractoriness, excitability and automaticity ( ,3) . In addi-
tion, these drugs may have different effects on normal and
abnormal areas of myocardium ( ) . It is probable that their
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after procainamide administration (p = 0 .00 ) . The an-
tidromic conduction intervals were prolonged by 9% (p =
0.06) compared with a 8% increase in the mean orthodro-
mic conduction interval (p = 0 .00 ) . The difference be-
tween the orthodromic and antidromic conduction intervals
increased by 40% (p = 0.003) . Prolongation of the tachy-
cardia cycle length after procainamide administration cor-
related positively with increases in the orthodromic conduc-
tion intervals (r = 0 .94, p = 0 .0 ) but not with changes in
the antidromic intervals (r = -0 .08, p = NS) . The effect of
procainamide on the difference between orthodromic and
antidromic conduction intervals correlated strongly with
changes in the cycle length of ventricular tachycardia (r =
0.97, p = 0 .006) .
Thus, procainamide has a preferential effect on the
reentrant circuit of ventricular tachycardia compared with
other areas of ventricular myocardium . In addition, these
results are compatible with the hypothesis that the effect of
procainamide is more marked in regions of conduction
delay in the reentrant circuit
.
(J Am Coll Cardiol 1989 ;14:38 -90)
net effect is a complex interaction of their effects on active
and passive membrane properties in normal and abnormal
regions (3) .
Sustained ventricular tachycardia related to coronary
artery disease in humans has been shown (4-13) to be
frequently based on a reentrant mechanism . Isochronal
endocardial mapping studies of human ventricular tachycar-
dia have demonstrated regions of slow conduction in ven-
tricular myocardium that may form the functional basis for a
reentrant circuit (13) . Further support for the existence of
slow conduction in the reentrant circuit in patients with
ventricular tachycardia has been provided by studies of the
response to rapid pacing during this arrhythmia (6-
10,14-16). The ability to continuously reset (transiently
entrain) ventricular tachycardia by rapid pacing has pro-
vided a method to determine the functional properties of
slowly conducting reentrant circuits (7,14) . With this tech-
nique, decremental conduction properties and localized
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block in these areas of conduction delay in human ventric-
ular tachycardia have been demonstrated (7,14) .
In this study, transient entrainment was used to test the
hypothesis that procainamide prolongs the cycle length of
ventricular tachycardia in patients with coronary artery
disease because of a preferential effect on slow conduction in
the reentrant tachycardia circuit compared with other re-
gions of myocardium .
Methods
Electrophysiologic study protocol . Patients with a history
of spontaneous sustained monomorphic ventricular tachy-
cardia who were referred for electrophysiologic testing were
studied prospectively. Electrophysiologic studies were per-
formed in the fasting state, at least four half-lives after
discontinuation of antiarrhythmic medications
. In all pa-
tients, quadripolar electrode catheters with 0
.5 cm interelec-
trode distance (USCI 6F Josephson) were introduced from
the femoral vein and positioned at the right ventricular apex
and outflow tract. A custom-designed octapolar catheter
(USCI 6F) was advanced from the femoral artery to the left
ventricle. Surface electrocardiographic (ECG) leads I, II, III
and V, and bipolar intracardiac electrograms filtered at a
bandpass of 30 to 500 Hz were recorded onto photographic
paper with use of a switched-beam oscilloscopic recorder
(Electronics for Medicine VR-16) and onto frequency-
modulated tape with use of a Honeywell 101 recorder . A
standard 1 lead ECG (Hewlett-Packard) was also recorded
during tachycardia .
Transient entrainment. Programmed electrical stimula-
tion was performed using a pulse width of .0 ms at twice the
diastolic current threshold . Sustained monomorphic ventric-
ular tachycardia was induced in all patients with one or two
extrastimuli coupled to an eight beat S, drive delivered from
the right ventricular apex . After a 1 lead ECG was re-
corded, rapid pacing was performed during ventricular
tachycardia from the right ventricular apex at a cycle length
10 to
0 ms less than that of the tachycardia. The pacing train
was started synchronously, with the first pacing stimulus
delivered at the tachycardia cycle length. Pacing was con-
tinued for 15 beats, then abruptly terminated
. If ventricular
tachycardia continued, rapid pacing at the same cycle length
was performed in the same manner sequentially from the
right ventricular outflow tract and from two sites in the left
ventricle . If ventricular tachycardia continued, the pacing
cycle length was decreased in decrements of 10 ms, and the
same sequence repeated until the tachycardia was inter-
rupted. With the catheters left in the same position, pacing
was also performed during sinus rhythm over the same range
of cycle lengths for 15 beats at each pacing site
.
Procainamide infusion . Procainamide (1
mg/kg body
weight) was infused intravenously over 30 min and pro-
grammed stimulation repeated
. After induction of sustained
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ventricular tachycardia, a 1 lead ECG was performed
. If the
configuration of ventricular tachycardia after procainamide
was identical to that induced in the baseline state, the same
rapid pacing protocol described earlier was repeated during
ventricular tachycardia and during sinus rhythm . Intervals
were measured at a paper speed of 100 mm/s .
Definitions. The criteria for transient entrainment have
been described previously (17) . A recording site was consid-
ered to have been activated orthodromically during transient
entrainment of ventricular tachycardia if 1) the local electro-
gram at that site during rapid pacing occurred at the pacing
cycle length and maintained a constant configuration during
both pacing and spontaneous ventricular tachycardia
; and )
after termination of pacing, the last captured local electro-
gram occurred at the pacing cycle length and was associated
with a nonfused QRS configuration identical to that of the
spontaneous ventricular tachycardia .
Experimental model . Figure 1 illustrates diagrammati-
cally the experimental model used in the study . In panel A,
a reentrant ventricular tachycardia circuit is shown, with
earliest activation of the ventricles occurring in the left
ventricle as the wave of depolarization emerges from a
region of slow conduction . The tachycardia loop is com-
pleted with reactivation of the proximal portion of the region
of slow conduction . With rapid ventricular pacing from the
right ventricle at a rate faster than ventricular tachycardia
(panel B), an excitable gap in the tachycardia circuit is
entered with resetting of the ventricular tachycardia . Each
paced wave front enters the region of slow conduction at the
proximal end and collides with the wave front of activation
from the previous beat . The tachycardia is reset continu-
ously to the faster pacing rate without being terminated, and
is, therefore, transiently entrained . The left ventricular (LV)
recording site distal to the region of slow conduction is
activated in the same direction during both transient entrain-
ment and spontaneous tachycardia by an orthodromic wave
front emerging from the region of slow conduction . In panel
C, pacing from the same right ventricular site during sinus
rhythm at the same rates that demonstrated transient en-
trainment activates the left ventricular recording site with a
short conduction time from a different direction by a wave
front of depolarization that does not traverse the region of
slow conduction . This wave front from the pacing stimulus is
designated as antidromic. The interval from the pacing
stimulus to the orthodromically activated local electrogram
was measured during transient entrainment of ventricular
tachycardia and designated the orthodromic conduction in-
terval (panel B)
. When more than one recording site dem-
onstrated orthodromic activation during transient entrain-
ment, only the site activated earliest in relation to the onset
of the surface QRS complex was considered .
With use of the same pacing rates, the interval from the
pacing stimulus to the same recording site that had been
activated orthodromically during transient entrainment of
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Figure 1. The experimental model is illustrated diagrammatically .
A, A reentrant circuit sustaining ventricular tachycardia is shown .
The orthodromic wave front emerges from a region of slow conduc-
tion (rectangle), with activation of the left ventricle (LV) . The
tachycardia circuit is completed as the orthodromic wave front
reenters the proximal region of slow conduction . Note that the right
ventricular apex (RVA) is not activated as a critical component of
the reentrant circuit . B, The activation sequence during transient
entrainment of ventricular tachycardia by pacing from the right
ventricular apex (RVA). C, Rapid pacing during sinus rhythm
activates the left ventricular (LV) recording site from a different
direction with a short conduction time without traversing the region
of slow conduction . See text for discussion .
ventricular tachycardia was measured during pacing in sinus
rhythm. This interval was designated the antidromic conduc-
tion interval (panel C) . The orthodromic interval includes the
time required for conduction from the pacing site to the
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tachycardia circuit, through the excitable gap and through
the region of slow conduction . The antidromic interval does
not include the time required for conduction through the
region of slow conduction . Orthodromic and antidromic
conduction intervals from the same pacing site to the same
recording site were also measured after procainamide infu-
sion in precisely the same manner . The difference between
the orthodromic and antidromic intervals at each paced
cycle length was also calculated . This interval may provide
insights relevant to the region, or regions, of slow conduc-
tion in the reentrant circuit .
Inclusion criteria . Patients were included in the study if
all of the following criteria were met : 1) patients had docu-
mented coronary artery disease by coronary arteriography,
segmental wall motion abnormalities by left ventriculogra-
phy, a documented history of myocardial infarction at least
6 months previously and no known intolerance to procaina-
mide ; ) sustained ventricular tachycardia with the same
QRS configuration in all 1 ECG leads was inducible in the
baseline state and after procainamide infusion ; 3) a recording
site was identified that demonstrated orthodromic activation
during transient entrainment with rapid pacing at two or
more cycle lengths before and after procainamide ; and 4)
rapid pacing from the same site during sinus rhythm at the
cycle lengths that demonstrated transient entrainment during
ventricular tachycardia before and after procainamide did
not induce ventricular arrhythmias .
Statistical analysis . Conduction intervals before and after
procainamide infusion were compared using the nonpara-
metric Mann-Whitney test . Conduction intervals were ex-
pressed as mean values ± SD . Correlation was performed
using Pearson's correlation coefficient .
Results
Study patients. Five patients with sustained ventricular
tachycardia met the entry criteria and were included in the
study (Tables 1 and ). In all patients, hemodynamically well
tolerated ventricular tachycardia was induced reproducibly
in the baseline state and after intravenous procainamide
administration by programmed electrical stimulation using
one or two extrastimuli . Both the first and second criteria for
transient entrainment were demonstrated for all episodes of
ventricular tachycardia . The mean serum procainamide level
achieved was 8 .4 ± 1 .9 mg/liter. The mean cycle length of
ventricular tachycardia prolonged from 3 3 ± 3 ms in the
baseline state to 410 ± 4 ms after procainamide, an increase
of 7% (p = 0.00 ). The effective refractory period of the
right ventricular apex prolonged from a mean of 3 .5 ± 15
ms baseline to 50 ± 18 ms after procainamide . The range of
pacing cycle lengths demonstrating transient entrainment of
ventricular tachycardia was 4 ± 5.5 ms at baseline and 30 ±
17.3 ms after procainamide (p = NS) . In all patients, this
*Procainamide serum levels expressed in mg/liter and conduction intervals expressed in milliseconds . Anti = antidromic conduction interval ; CL =
ventricular tachycardia cycle length ; ERP = effective refractory period : LBBB = left bundle branch block ; QRS = QRS configuration during ventricular
tachycardia ; 0-A = orthodromic minus antidromic interval ; Orth = orthodromic conduction interval ; Range = range of pacing cycle lengths demonstrating
transient entrainment
; RBBB = right bundle branch block ; SD = standard deviation .
range was the same or greater after procainamide than in the
baseline state .
Effects of procainamide on ventricular tachycardia conduc-
tion intervals (Fig .
to 5)
. In patient 1 (Fig . A), ventricular
tachycardia with a right bundle branch block configuration is
entrained transiently by rapid pacing at a cycle length of 300
ms from the right ventricular apex . Note that the last
captured electrogram at the left ventricular (LV)1- record-
ing site (asterisk) is activated at the pacing cycle length with
a constant configuration and is associated with a nonfused
surface QRS complex and the same intracardiac activation
sequence noted during spontaneous ventricular tachycardia .
The orthodromic conduction interval measured 440 ms . In
panel
B, rapid pacing from the right ventricular apex at a
cycle length of 300 ms activates the LV 1-
recording site
with an antidromic conduction time of 155 ms . Transient
entrainment of ventricular tachycardia after procainamide
administration (panel C) activates the LV1- recording site
with an orthodromic conduction time of 545 ms . The antidro-
mic conduction time at the same pacing cycle length (360 ms)
after procainamide prolonged to 185 ms (panel D). The
results for Patient I at each paced cycle length are illustrated
in Figure 3 .
Orthodromic and antidromic conduction intervals before
and after procainamide are shown for the entire group in
Figures 4 and 5 .
The mean antidromic conduction interval
Table
. Effects of Procainamide on Conduction Intervals in
Five Patients
VT Cycle
	
Ortho-Anti
Length Antidromic Orthodromic
Interval
(+) 7 ± 7% (+) 9 ± 8% (+) 8 ± 8% (+) 40 ± 13%
p = 0.00 p = 0 .06 p = 0.00 p = 0
.003
Values expressed as mean percentage change after procainamide com-
pared to baseline ± standard deviation . Ortho-Anti = orthodromic minus
antidromic interval ; VT = ventricular tachycardia .
prolonged by 9%, from 146 ± 11 ms before, to 159 ± 18
ms after procainamide (p = 0 .06). The mean orthodromic
conduction interval increased by 8%, from 414 ± 51 ms
in the baseline state to 533 ± 74 ms after procainamide
(p = 0 .00 ) . The difference between the orthodromic and
antidromic conduction intervals increased by 40% after
procainamide from a mean of 68 ± 43 to 373 ± 64 ms
(p = 0 .003) .
Relation of changes in ventricular tachycardia cycle length
to changes in orthodromic and antidromic conduction inter-
vals produced by procainamide (Fig . 6) . Increases in the
ventricular tachycardia cycle length correlated with changes
in the orthodromic conduction intervals (r = 0 .94, p = 0 .0 ),
but not with changes in the antidromic conduction interval
(r = -0.08, p = NS). The difference between orthodromic
and antidromic conduction intervals also demonstrated a
strong correlation with changes in the cycle length of ven-
tricular tachycardia (r = 0 .97, p = 0.006) .
Discussion
Region of slow conduction in ventricular tachycardia . The
mechanism of sustained monomorphic ventricular tachycar-
dia related to previous myocardial infarction has been shown
to be based on reentry with a gap of excitability in many
patients
(4) . The presence of a region of slow conduction as
a critical component of the reentrant ventricular tachycardia
circuit in humans has also been demonstrated previously
(7,13,14) . With the use of transient entrainment techniques,
decremental conduction properties and localized block in a
region of slow conduction have also been demonstrated
(7,14) .
The results of our study suggest that procainamide
prolongs the cycle length of ventricular tachycardia related
to previous myocardial infarction by a preferential effect on
slow conduction in the reentrant tachycardia circuit .
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Table 1 . Effects of Procainamide in Five Patients
Baseline
Procainamide
Patient
No . QRS CL Orth Anti 0-A ERP Range CL Orth Anti
0-A ERP Range
Serum
Level
1 RBBB 330 440 155 85 5 0 390 545 185 360 40 0 7 .5
LBBB 350 475
155 3 0 15 0 480 653 170 483 5 0 7 .0
3 LBBB 330 4 5 150 75 45 0 400 505 15 353 60 0 10 .5
4 RBBB
3 0 390 130 60 - 30 410 510 150 360 70 60 10 .3
5 LBBB 88 340 138 0 45 30 370 455 140 315 55
30 6 .5
Mean 3 4 414 146 68 33 4 410 533 159 374 50 30 8 .4
± SD 3 51
11
43 15 6 4 4
18 64 18 17 1 .9
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Figure . Patient 1 . Determination of orthodromic and antidromic
conduction intervals in the absence of antiarrhythmic drugs (A and
B) and after intravenous procainamide infusion (C and D) . Surface
electrocardiographic (ECG) leads I, II, III and V, are recorded
simultaneously with intracardiac electrograms from the right ven-
tricular apex proximal (RVAp) and distal (RVAd), right ventricular
outflow tract proximal (RVOTp) and distal (RVOTd) and left ven-
tricular electrode pairs 7 to 8 (LV 7.), 5 to 6 (LV 5-6 ), 3 to 4 (LV
3-4
)
and I to (LV 1_ ) . A, Rapid pacing at a cycle length of 300 ms from
the right ventricular apex distal (RVAd) electrode pair during
ventricular tachycardia activates all recording sites at the paced
cycle length . After termination of pacing, ventricular tachycardia
continues with the last captured beat in the most distal left ventric-
ular electrode pair (LV 1 _ ) occurring at the paced cycle length
(asterisk) . The QRS configuration in the surface ECG leads of the
last captured beat (star) is not fused but is identical to that during
ventricular tachycardia. B, Rapid pacing from the right ventricular
apex distal (RVAd) electrode pair at a cycle length of 300 ms during
sinus rhythm . After termination of pacing, sinus rhythm resumes .
Preferential effect of procainamide on reentrant circuit .
The observation that procainamide prolonged the cycle
length and orthodromic conduction intervals of ventricular
tachycardia to a proportionately greater extent than the
antidromic conduction intervals is evidence of a preferential
effect on the reentrant circuit of ventricular tachycardia .
Because the difference between orthodromic and antidromic
intervals was prolonged to a greater degree than either the
antidromic or orthodromic intervals, it is likely that this
effect of procainamide occurred in a region of slow conduc-
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The configuration of the LV,_ electrogram during pacing at the
same cycle length in ventricular tachycardia (A) is different from
that during pacing in sinus rhythm (B) . The interval from the last
pacing stimulus (S) to the LV1- recording site measures 155 ms and
is termed the antidromic conduction interval . C, Rapid pacing at a
cycle length of 360 ms during ventricular tachycardia is performed
after intravenous administration of procainamide . The QRS config-
uration and intracardiac activation sequence during ventricular
tachycardia after procainamide are the same as in A in the absence
of antiarrhythmic drugs . After termination of pacing, ventricular
tachycardia continues with the last captured beat in the LV 1 _
recording site occurring at the paced cycle length (asterisk) . The
QRS configuration of the last captured beat is identical to that during
spontaneous ventricular tachycardia (star) . The orthodromic inter-
val from the pacing stimulus (S) to the last entrained electrogram
(asterisk) measures 545 ms after procainamide . D, Rapid pacing from
the right ventricular apex distal (RVAd) electrode pair at a cycle
length of 360 ms during sinus rhythm after procainamide . The
antidromic interval measures 185 ms . See text for discussion .
tion. However, because the orthodromic interval includes
conduction from the pacing site, and through both an excit-
able gap and a region (or regions) of slow conduction, our
data do not prove that the preferential effect of procainamide
occurred only in a region of conduction delay . For example,
a partially excitable gap in the reentrant circuit potentially
may respond to antiarrhythmic drugs in a similar manner .
However, because the range of pacing cycle lengths that
demonstrated transient entrainment of ventricular tachycar-
dia was either the same or greater after procainamide than in
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Figure 3 . The orthodromic (open circles) and antidromic (closed
circles) conduction intervals at baseline and after procainamide for
Patient I (Fig . ) are illustrated over the range of pacing cycle
lengths (CL) demonstrating transient entrainment . The gradual
prolongation of the orthodromic conduction intervals at shorter
paced cycle lengths before and after procainamide is evidence of
progressive conduction delay in the tachycardia circuit . There is no
change in the antidromic intervals at shorter pacing cycle lengths .
Vertical arrows and adjacent numbers indicate the difference be-
tween orthodromic and antidromic conduction intervals at each
pacing cycle length .
the baseline state, localization of drug effect to a partially
excitable gap seems unlikely . Therefore, although the avail-
able data do not allow precise localization of the effect of
procainamide between the functional components of the
reentrant circuit, the results are compatible with the hypoth-
esis that it is a region of slow conduction in the tachycardia
circuit that is most susceptible to the effects of this agent .
Potential mechanisms for a preferential effect of procaina-
mide on the ventricular tachycardia circuit . There are sev-
eral potential mechanisms by which procainamide may pref-
erentially affect the reentrant circuit . Previous studies (18) of
ventricular myocardium resected at the time of surgery for
refractory ventricular arrhythmias have demonstrated re-
duced resting membrane potentials and diminished action
potential amplitude and duration in infarcted regions . Con-
duction block and decremental properties have also been
demonstrated in these areas (18) . The anatomic and func-
tional substrate for the development of reentry in infarcted
human ventricular myocardium may be related to islands of
viable myocardium within or at the border of scar tissue that
KAY ET AL . 387
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Figure 4. Orthodromic (open circles) and antidromic (closed circles)
conduction intervals at the minimal pacing cycle length demonstrat-
ing transient entrainment before and after procainamide are illus-
trated for all five patients . The vertical axis indicates the conduction
interval from the last pacing stimulus to the last captured electro-
gram at a site that was activated orthodromically during transient
entrainment of ventricular tachycardia . The horizontal axis indicates
the baseline state and after procainamide . The effect of procaina-
mide was greater for orthodromic than for antidromic conduction .
See text for discussion .
are linked to normal myocardium by strands of slowly
conducting but viable myocardium ( ,19) . If slow conduction
is present in a functional isthmus between damaged and
normal areas of the ventricle, this area may be more suscep-
tible to the effects of procainamide than are more normal
areas ( ) . For example, previous canine studies ( 0) have
shown that surgical creation of a narrow isthmus of atrial
muscle joining two broader sheets of normal myocardium
results in a region that is vulnerable to conduction block
during pacing from either side of the isthmus . The site of
block in these preparations is at the distal end of the isthmus
near the junction with the broader mass of myocardium .
In more recent studies using this experimental model,
Inoue and Zipes ( 1) showed that procainamide lengthens
the effective refractory period of the isthmus to a far greater
extent than it does in regions proximal or distal to this site .
Similar findings of a low safety margin for conduction have
been demonstrated at the junction of Purkinje fibers and
Baseline
Procainamide
p = 0 .00
p = 0 .06
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Baseline Procainamide
Figure 5 . Effect of procainamide on the calculated difference be-
tween orthodromic and antidromic (Ortho-Anti) conduction inter-
vals (vertical axis) is plotted against the change in ventricular
tachycardia cycle length (CL) induced by procainamide (horizontal
axis) . The change in this value is strongly associated with the change
in ventricular tachycardia cycle length produced by procainamide .
See text for discussion .
ordinary ventricular muscle cells ( ) . The vulnerability of
such sites to failure of impulse propagation has been postu-
lated to be due to a mismatch of impedance at the junction of
the narrow bridge of tissue and the broader mass of myocar-
dium ( , 3) . This might result in failure of the depolarizing
wave front traversing the smaller connecting bridge (source)
to produce a regenerative response in the larger ventricular
mass (sink) because of dilution of electrotonic effect by the
many low resistance connections between these regions
( 1, ). If the safety margin for impulse propagation (the
excess of source over sink required to produce a regen-
erative response) at the junction of a region of slow con-
duction to less damaged areas of ventricular myocardium is
low, procainamide could potentially slow conduction at this
site to a greater degree than in other areas of the ventricle
( 1) .
Potential role of anisotropy . The relative selectivity of
procainamide on the reentrant circuit could also be related to
anisotropy in these zones ( 4, 5). The geometry of fiber
orientation has been shown to influence conduction velocity
at branch sites from smaller to larger fiber diameter ( 6) .
Spach et al . ( 4) demonstrated the importance of fiber
orientation on both the rate of impulse propagation and the
upstroke velocity of the action potential in normal canine
myocardium. In addition, Kadish et al . ( 5) demonstrated
that procainamide retards conduction in the longitudinal axis
-0-
p - 0 .003
150
1 5
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Figure 6. The difference between orthodromic and antidromic
(Ortho-Anti) conduction intervals at the minimal pacing cycle
length (CL) demonstrating transient entrainment before and after
procainamide . This difference may provide information relevant to a
region, or regions, of slow conduction in the reentrant ventricular
tachycardia circuit . See text for discussion .
of myocardial fibers to a proportionally greater degree than it
does in the transverse axis .
Potential role of partially depolarized myocardium . Con-
duction velocity can also be expected to decrease in the
presence of decreased sodium conductance ( 7, 8). Because
blockade of sodium channels by antiarrhythmic drugs may
depend on the proportion of time that the channels are open,
relatively depolarized cells in slowly conducting portions of
the tachycardia circuit may be more likely to bind sodium
channel blocking agents ( 9-35). In addition, altered kinetics
of activation and inactivation gating may be present in the
reentrant circuit and could result in enhancement of the
sodium channel blocking effect of procainamide .
Previous studies of procainamide . Previous studies (36) of
procainamide in patients with ventricular tachycardia related
to coronary artery disease have suggested a uniform prolon-
gation of electrogram duration in normal and abnormal areas
of ventricular myocardium during sinus rhythm . However,
regions of conduction delay in the reentrant tachycardia
circuit may not be evident during pacing in sinus rhythm (7) .
The results of the present study suggest that the properties of
the reentrant circuit can be accurately assessed only by
recording during reentry .
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Limitations of study . Several important limitations
should be emphasized . Various factors suggest that the
study population was highly selected . First, procainamide
failed to suppress induction of ventricular tachycardia in all
patients . Only the five patients in whom the same configura-
tion of ventricular tachycardia could be induced in both the
baseline state and after procainamide infusion were in-
cluded . Second, transient entrainment could be demon-
strated for all five patients, indicating that reentry with an
excitable gap was the likely mechanism . Third, all five
patients had coronary artery disease and prior myocardial
infarction as the underlying anatomic substrate . Lastly,
ventricular tachycardia was well tolerated by all patients,
allowing completion of the study protocol . Whether patients
with other forms of structural heart disease, shorter cycle
lengths of ventricular tachycardia or other mechanisms of
tachycardia would have similar responses to procainamide is
uncertain . In addition, whether procainamide suppresses the
induction of ventricular tachycardia by a similar action on
the region of slow conduction is unknown .
Conclusions . Our results have implications for under-
standing the mechanism of action of antiarrhythmic drugs on
the functional components of human ventricular tachycar-
dia. These data suggest that procainamide slows the rate of
ventricular tachycardia related to prior myocardial infarction
by a preferential effect on the reentrant tachycardia circuit in
comparison with other regions of ventricular myocardium .
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